IS7165A - 17alfa-hýdroxý-14beta-sterar með hormónavirkni - Google Patents

17alfa-hýdroxý-14beta-sterar með hormónavirkni

Info

Publication number
IS7165A
IS7165A IS7165A IS7165A IS7165A IS 7165 A IS7165 A IS 7165A IS 7165 A IS7165 A IS 7165A IS 7165 A IS7165 A IS 7165A IS 7165 A IS7165 A IS 7165A
Authority
IS
Iceland
Prior art keywords
14beta
17alpha
steroids
hydroxy
hormonal activity
Prior art date
Application number
IS7165A
Other languages
English (en)
Other versions
IS2555B (is
Inventor
Van Der Louw Jaap
Evert De Gooijer Marcel
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8180920&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7165(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of IS7165A publication Critical patent/IS7165A/is
Publication of IS2555B publication Critical patent/IS2555B/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0062Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16Masculine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7165A 2001-09-12 2004-02-26 17alfa-hýdroxý-14beta-sterar með hormónavirkni IS2555B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203455 2001-09-12
PCT/EP2002/010041 WO2003022864A1 (en) 2001-09-12 2002-09-06 17alpha-hydroxy-14beta-steroids with hormonal effect

Publications (2)

Publication Number Publication Date
IS7165A true IS7165A (is) 2004-02-26
IS2555B IS2555B (is) 2009-10-15

Family

ID=8180920

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7165A IS2555B (is) 2001-09-12 2004-02-26 17alfa-hýdroxý-14beta-sterar með hormónavirkni

Country Status (28)

Country Link
US (1) US7169769B2 (is)
EP (1) EP1427748B1 (is)
JP (1) JP4471653B2 (is)
KR (1) KR100940054B1 (is)
CN (1) CN1257913C (is)
AR (1) AR036462A1 (is)
AT (1) ATE395352T1 (is)
AU (1) AU2002339536B2 (is)
BR (1) BR0212409A (is)
CA (1) CA2505575C (is)
CY (1) CY1108152T1 (is)
DE (1) DE60226623D1 (is)
DK (1) DK1427748T3 (is)
EC (1) ECSP045012A (is)
ES (1) ES2305306T3 (is)
HR (1) HRP20040193A2 (is)
HU (1) HUP0402139A3 (is)
IL (2) IL160451A0 (is)
IS (1) IS2555B (is)
MX (1) MXPA04002418A (is)
NO (1) NO326624B1 (is)
NZ (1) NZ531487A (is)
PL (1) PL207493B1 (is)
PT (1) PT1427748E (is)
RU (1) RU2294332C2 (is)
TW (1) TWI221154B (is)
WO (1) WO2003022864A1 (is)
ZA (1) ZA200401992B (is)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3338925A (en) * 1965-10-25 1967-08-29 Syntex Corp 17-substituted 14beta-estr-4-enes
WO2000053619A1 (en) * 1999-03-08 2000-09-14 Akzo Nobel N.V. 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
AU4299301A (en) * 2000-02-29 2001-09-12 National University Of Singapore, The A method for modulating steroidogenic activity
US6391868B2 (en) * 2000-05-10 2002-05-21 Lpt Research, Inc. Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans
TWI221154B (en) 2001-09-12 2004-09-21 Akzo Nobel Nv 17alpha-hydroxy-14beta-steroids with hormonal effect

Also Published As

Publication number Publication date
PL368727A1 (en) 2005-04-04
HK1063637A1 (en) 2005-01-07
EP1427748B1 (en) 2008-05-14
HUP0402139A3 (en) 2012-12-28
HUP0402139A2 (hu) 2005-02-28
CN1257913C (zh) 2006-05-31
HRP20040193A2 (en) 2004-08-31
IL160451A (en) 2009-11-18
PL207493B1 (pl) 2010-12-31
IL160451A0 (en) 2004-07-25
CA2505575A1 (en) 2003-03-20
NZ531487A (en) 2005-08-26
ECSP045012A (es) 2004-09-27
KR20040039346A (ko) 2004-05-10
DE60226623D1 (de) 2008-06-26
US7169769B2 (en) 2007-01-30
WO2003022864A1 (en) 2003-03-20
RU2294332C2 (ru) 2007-02-27
AU2002339536B2 (en) 2008-04-24
JP4471653B2 (ja) 2010-06-02
EP1427748A1 (en) 2004-06-16
AR036462A1 (es) 2004-09-08
CA2505575C (en) 2010-01-26
PT1427748E (pt) 2008-08-27
BR0212409A (pt) 2004-08-03
CN1553917A (zh) 2004-12-08
MXPA04002418A (es) 2004-07-30
IS2555B (is) 2009-10-15
CY1108152T1 (el) 2014-02-12
ATE395352T1 (de) 2008-05-15
US20040259849A1 (en) 2004-12-23
KR100940054B1 (ko) 2010-02-04
NO326624B1 (no) 2009-01-19
ES2305306T3 (es) 2008-11-01
ZA200401992B (en) 2005-04-21
TWI221154B (en) 2004-09-21
RU2004110934A (ru) 2005-08-20
DK1427748T3 (da) 2008-09-08
NO20041010L (no) 2004-03-10
JP2005505566A (ja) 2005-02-24

Similar Documents

Publication Publication Date Title
ATE294292T1 (de) Hauptträgerverbindung
DE50203101D1 (de) Schraubstation
DE60209431D1 (de) Sitzstruktur
DE60207518D1 (de) Dämpfungseinrichtung
IS2421B (is) Nýir etónógestrel esterar
NO20014597D0 (no) Fremgangsmåte
NO20024455D0 (no) V¶skeströmningsregulator
NO20035501D0 (no) Vaskev¶skefordelingssystem
ATA16142000A (de) Plattenaufteilsäge
DE50207870D1 (de) Abschlussbandage
DE50204799D1 (de) Rückenlehne
AT503224A3 (de) Holzbautafel
EP1457259A4 (en) Photocatalyst
IS7165A (is) 17alfa-hýdroxý-14beta-sterar með hormónavirkni
DE50208656D1 (de) Kopfaufpralloptimierte frontstruktur
DE60237655D1 (de) Entwicklungsgerät
DK1348606T3 (da) Sporskifte-indstillingssystem
FR2851150B3 (fr) Structure de grille-pain
DE60112036D1 (de) Uhrwerk
DE50201354D1 (de) Schraubstation
NO20026215L (no) Nytt hormonpreparat
AR028422A1 (es) Indanilimizadoles policeclicos nuevos con actividad adrencrgica alfa2
ATA14002001A (de) Tragwerk
AT9849U3 (de) Holzbautafel
NO20014710D0 (no) Utaskj¶rsheis